http://www.fda.gov/cder/orange/appendix_a.txt 3, ACETAMINOPHEN ACETAMINOPHEN W/ CODEINE PHOSPHATE #3, ACETAMINOPHEN ACETAMINOPHEN W/ CODEINE PHOSPHATE, ACETAMINOPHEN ACETAMINOPHEN W/ CODEINE, ACETAMINOPHEN ACETAMINOPHEN, ACETAMINOPHEN (OTC) ACETAMINOPHEN, ASPIRIN AND CAFFEINE, ACETAMINOPHEN (OTC) ACETAMINOPHEN, ASPIRIN, AND CODEINE PHOSPHATE, ACETAMINOPHEN ACETAMINOPHEN, BUTALBITAL AND CAFFEINE, ACETAMINOPHEN ACETAMINOPHEN,...
NDA Approvals for Calendar Year 2003 NDA APPROVALS FOR CALENDAR YEAR 2003 Updated through December 31, 2003 NDA NUMBER DRUG NAME GENERIC NAME APPLICANT/ SPONSOR CHEMICAL TYPE THERAPEUTIC CLASS APPROVAL DATE - 21434 Xanax XR Alprazolam Pharmacia and Upjohn FR 3 S 17-Jan-03 21305 Sodium Iodide I-131 Sodium Iodide I-131 DraxImage 3,5 S 24-Jan-03 20414 Pyridostigmine Bromide Pyridostigmine Bromide US Army 3 P 05-Feb-03...
author: Susan Daugherty
Prescription and Over-the-Counter Drug Product List: 7/2003 ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST ACETAMINOPHEN; PROPOXYPHENE HYDROCHLORIDE TABLET; ORAL PROPOXYPHENE HCL AND ACETAMINOPHEN >A> AA VINTAGE PHARMS 650MG;65MG N40507 001 JUL 30, 2003 JUL NEWA ACYCLOVIR TABLET; ORAL ACYCLOVIR >D> AB CLONMEL HLTHCARE 400MG N74834 001 APR 24, 1997 JUL DISC >A> @ 400MG N74834 001 APR 24, 1997 JUL DISC >D> AB 800MG N74834 002 APR 24,...
author: AUTHOR
NDA-I2: NDA Approval Letter page 22
author: SUZANNE CHILDS
subject: NDA Approval Letter - FPL acceptable
NDA-I2: NDA Approval Letter page 18
author: SUZANNE CHILDS
subject: NDA Approval Letter - FPL acceptable
NDA-I2: NDA Approval Letter page 16
author: SUZANNE CHILDS
subject: NDA Approval Letter - FPL acceptable
NDA-I2: NDA Approval Letter page 15
author: SUZANNE CHILDS
subject: NDA Approval Letter - FPL acceptable
NDA-I2: NDA Approval Letter page 14
author: SUZANNE CHILDS
subject: NDA Approval Letter - FPL acceptable
NDA-I2: NDA Approval Letter page 13
author: SUZANNE CHILDS
subject: NDA Approval Letter - FPL acceptable
NDA-I2: NDA Approval Letter page 12
author: SUZANNE CHILDS
subject: NDA Approval Letter - FPL acceptable
NDA-I2: NDA Approval Letter page 11
author: SUZANNE CHILDS
subject: NDA Approval Letter - FPL acceptable
NDA-I2: NDA Approval Letter page 10
author: SUZANNE CHILDS
subject: NDA Approval Letter - FPL acceptable
NDA-I2: NDA Approval Letter page 9
author: SUZANNE CHILDS
subject: NDA Approval Letter - FPL acceptable
NDA-I2: NDA Approval Letter page 8
author: SUZANNE CHILDS
subject: NDA Approval Letter - FPL acceptable
NDA-I2: NDA Approval Letter page 7
author: SUZANNE CHILDS
subject: NDA Approval Letter - FPL acceptable
NDA-I2: NDA Approval Letter page 6
author: SUZANNE CHILDS
subject: NDA Approval Letter - FPL acceptable
NDA-I2: NDA Approval Letter page 5
author: SUZANNE CHILDS
subject: NDA Approval Letter - FPL acceptable
NDA-I2: NDA Approval Letter page 4
author: SUZANNE CHILDS
subject: NDA Approval Letter - FPL acceptable
NDA-I2: NDA Approval Letter page 3
author: SUZANNE CHILDS
subject: NDA Approval Letter - FPL acceptable
NDA-I2: NDA Approval Letter page 2
author: SUZANNE CHILDS
subject: NDA Approval Letter - FPL acceptable
NDA-I2: NDA Approval Letter page 1
author: SUZANNE CHILDS
subject: NDA Approval Letter - FPL acceptable
NDA-I2: NDA Approval Letter page 1
author: SUZANNE CHILDS
subject: NDA Approval Letter - FPL acceptable
Forum - Read Topic Dupuytren's Disease Patient Discussion Forum - Topic: "Fasciotomy vs.
Topical corticosteroids for atopic dermatitis - [Medication] - Quest Diagnostics Patient Health Library Topic Contents - Examples - How It Works - Why It Is Used - How Well It Works - Side Effects - What To Think About - References Topical corticosteroids for atopic dermatitis - [Medication] - Quest Diagnostics Patient Health Library Topical corticosteroids for atopic dermatitis - [Medication] - Quest Diagnostics Patient Health Library anti-itch medications, antipruritic medications,...
Database C C - investigational drugs, therapies and vaccines # - A - B - C - D - E - F - G - H - I - J - K - L - M - N - O - P - Q - R - S - T - U - V - W - X - Y - Z From this page you may order documents with information covering investigational products.
